530057
VIVANZA
Invest Now
Start SIP in
VIVANZA
Performance
- Low
- ₹2
- High
- ₹2
- 52 Week Low
- ₹2
- 52 Week High
- ₹5
- Open Price₹2
- Previous Close₹2
- Volume92,175
Investment Returns
- Over 1 Month -12.66%
- Over 3 Month -9.21%
- Over 6 Month -39.12%
- Over 1 Year -57.76%
Smart Investing Starts Here Start SIP with Vivanza Biosciences for Steady Growth!
Vivanza Biosciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -12.3
- PEG Ratio
- 0.1
- Market Cap Cr
- 8
- P/B Ratio
- 1.7
- Average True Range
- 0.1
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -0.06
- RSI
- 40.38
- MFI
- 46.44
Vivanza Biosciences Financials
Vivanza Biosciences Technicals
EMA & SMA
Current Price
₹2.07
-0.06
(-2.82%)

-
- Bearish Moving Average 16
-
- Bullish Moving Average 0
- 20 Day
- ₹2.16
- 50 Day
- ₹2.24
- 100 Day
- ₹2.44
- 200 Day
- ₹3.14
Resistance and Support
2.09
- R3 2.22
- R2 2.18
- R1 2.13
- S1 2.04
- S2 2.00
- S3 1.95
Vivanza Biosciences Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-05-12 | Audited Results | |
2025-01-31 | Quarterly Results & Others | To consider other business matters. split from Rs. 10/- to Re. 1/-. |
2024-10-17 | Quarterly Results | |
2024-08-08 | Quarterly Results | |
2024-07-05 | Others | Inter alia, 1) To consider and approve the Director's Report and Secretarial Audit Report along with annexure for the F.Y. 2023-24; split from Rs. 10/- to Re. 1/-. |
Vivanza Biosciences F&O
About Vivanza Biosciences
- NSE Symbol
- VIVANZA
- BSE Symbol
- 530057
- Managing Director
- Mr. J A Mehta
- ISIN
- INE984E01035
Similar Stocks to Vivanza Biosciences
Vivanza Biosciences FAQs
Vivanza Biosciences share price is ₹2 As on 15 July, 2025 | 22:34
The Market Cap of Vivanza Biosciences is ₹8.3 Cr As on 15 July, 2025 | 22:34
The P/E ratio of Vivanza Biosciences is -12.3 As on 15 July, 2025 | 22:34
The PB ratio of Vivanza Biosciences is 1.7 As on 15 July, 2025 | 22:34
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.